医療食品のヨーロッパ市場2022~2030:投与経路別、製品タイプ別、用途別、販売チャネル別、国別

調査会社Grand View Research社が発行したリサーチレポート(データ管理コード:GRV22JL005)
■ 英語タイトル:Europe Medical Foods Market Size, Share & Trends Analysis Report By Route Of Administration, By Product Type, By Application, By Sales Channel, By Country, And Segment Forecasts, 2022 - 2030
■ 発行会社/調査会社:Grand View Research
■ 商品コード:GRV22JL005
■ 発行日:2022年5月24日
■ 調査対象地域:ヨーロッパ
■ 産業分野:医薬品
■ ページ数:150
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後3営業日)
■ 販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥791,350見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥924,350見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,190,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[医療食品のヨーロッパ市場2022~2030:投与経路別、製品タイプ別、用途別、販売チャネル別、国別]についてメールでお問い合わせはこちら
グランドビューリサーチ社は、ヨーロッパの医療食品市場規模が2022年から2030年までの間に年平均2.9%成長し、2030年までに72億ドルに達すると予測しています。本調査レポートでは、医療食品のヨーロッパ市場について調査し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、競争分析、投与経路別分析、製品別分析、用途別分析、販売チャネル別分析、地域別分析、競争状況など、以下の構成でお届け致します。本調査レポートでは、DANONE、NESTLE、ABBOTT、TARGETED MEDICAL PHARMA INC、MEAD JOHNSON & COMPANY, LLC、FRESENIUS KABI AGなどの企業情報が含まれております。
*** レポート概要(サマリー)***

Europe Medical Foods Market Growth & Trends
The Europe medical foods market size is anticipated to hit USD 7.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.9% from 2022 to 2030. The ever-increasing burden of chronic diseases and the growing geriatric population across Europe are primary reasons for the market to flourish. In 2021, the oral route of administration accounted for the largest revenue share of 69.5%. Ease of use and high availability of medical foods in this form has contributed to the high revenue. The enteral route of administration is expected to register the fastest growth. This can be attributed to the growing geriatric population suffering from chronic diseases who are unable to consume food orally. The enteral route of administration seems to be the preferred way of administrating nutrients through medical foods to the specific needs of geriatric patients.

In the product type, the powder formulations held the largest revenue share in 2021. Owing to the vast product portfolios available in this formulation this segment has grown to a large extent. Powder formulations include nutrient mixes, protein shakes, and infant feeding formulas. The highest growth was registered by the liquid formulations due to the diversification of product portfolios of the key players in the medical foods industry. Chemotherapy-induced diarrhea had the largest revenue share in 2021 in the applications segment. Nutritional deficiency in cancer patients is a major concern and can be managed through proper nutrient management via medical foods and is a major factor in its growth. The fastest-growing sub-segment is diabetic neuropathy, high prevalence, and has been a key driver for its fast growth.

The largest sales channel for 2021 was institutional sales, owing to the dependency of key players on representatives who directly provide products to physicians and clinicians at hospitals and clinics has accounted for the growth. The fastest-growing sales channel is online sales due to the ease of use of this channel, consumers can directly purchase specific needs FSMP products from the company websites or third-party websites reducing the number of visits to care centers and hospitals. The pandemic has made people realize the importance of good health and nutrition. Even though the supply chain of almost every business was affected, the market is expected to recover at a fast pace owing to the surge in demand for medical foods. An increase in demand for immunity-boosting foods and an increase in the number of people suffering from chronic illnesses have had a positive impact on the market.

Europe Medical Foods Market Report Highlights

• Based on route of administration, the oral segment accounted for the largest revenue share of 69.5% in 2021 owing to high product type availability and ease of administration

• In 2021, the powder formulation segment accounted for the largest revenue share of 35.4% owing to the majority product portfolio available in the market

• By application, the diabetic neuropathy segment is expected to witness the fastest growth over the forecast period owing to the high disease burden of the disease across Europe

• The institutional sales channel had the largest share, but the online sales channel is expected to grow at a steady rate owing to the preference of consumers and key player initiatives for sales through online channels

*** レポート目次(コンテンツ)***

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Research Methodology
1.2.1 Information Procurement
1.2.1.1 Purchased database:
1.2.1.2 GVR’s internal database
1.2.2 Primary Research:
1.2.3 Research Methodology:
1.3 Research Scope and Assumptions
1.4 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Europe Medical Foods Market Snapshot
Chapter 3 Europe Medical Foods Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.1.1 Nutritional Supplements Market
3.1.2 Ancillary Market Outlook
3.1.2.1 Parenteral Nutrition market:
3.1.2.2 Enteral Feeding Devices Market
3.2 Penetration and Growth Prospect Mapping
3.3 Pricing Analysis
3.4 User Perspective Analysis
3.4.1 Consumer Behavior Analysis
3.4.2 Market Influencer Analysis
3.4.3 Key End-users
3.5 Technology Outlook
3.5.1 Technology Timeline
3.6 Market Dynamics
3.6.1 Market Driver Analysis
3.6.2 Market Restraint Analysis
3.6.3 Industry Challenges
3.7 Europe Medical Foods Market Analysis Tools
3.7.1 Europe Medical Foods Market – Pestle Analysis
3.7.2 Industry Analysis – Porter’s
3.8 Major Deals & Strategic Alliances Analysis
3.9 Market Entry Strategies
3.10 Prevalence of Health Conditions in Europe (2016 – 2030)
3.10.1 Chronic Kidney Disease
3.10.2 Minimal Hepatic Encephalopathy
3.10.3 Chemotherapy-Induced Diarrhea
3.10.4 Pathogen Related Infections
3.10.5 Diabetic Neuropathy
3.10.6 ADHD
3.10.7 Depression
3.10.8 Alzheimer’s Disease
3.10.9 Nutritional Deficiency
3.10.10 Chronic Wound
3.10.11 Chronic Diarrhea
3.10.12 Constipation
3.10.13 Dysphagia (Swallowing Disorder)
3.10.14 Orphan Diseases
3.10.14.1 Phenylketonuria
3.10.14.2 Eosinophilic Esophagitis
3.10.14.3 FPIES
3.10.14.4 Others
3.11 Impact of COVID-19 on Europe Medical Foods Market
Chapter 4 Europe Medical Foods Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
4.3 Vendor Landscape
4.3.1 List Of Key Distributors And Channel Partners
4.3.2 Key Company Market Share Analysis, 2021
4.4 Public Companies
4.4.1 Company Market Position Analysis
4.4.2 Company Market Ranking By Region
4.5 Private Companies
4.5.1 Regional Map
4.5.2 Company Market Position Analysis
Chapter 5 Europe Medical Foods Market: Route of Administration Estimates & Trend Analysis
5.1 Europe Medical Foods Market: Route of Administration (ROA) Movement Analysis, 2021 & 2030, USD Million
5.2 Oral
5.2.1 Oral Medical Foods Market Estimates And Forecasts, 2016 – 2030 (USD Million)
5.3 Enteral
5.3.1 Enteral Medical Foods Market Estimates And Forecasts, 2016 – 2030 (USD Million)
Chapter 6 Europe Medical Foods Market: Products Estimates & Trend Analysis
6.1 Europe Medical Foods Market: Product Movement Analysis, 2021 & 2030, USD Million
6.2 Pills
6.2.1 Europe Medical Foods Market Estimates And Forecasts For Pills Formulation, 2016 – 2030 (USD Million)
6.3 Powder
6.3.1 Europe Medical Foods Market Estimates And Forecasts For Powder Formulation, 2016 – 2030 (USD Million)
6.4 Others
6.4.1 Europe Medical Foods Market Estimates And Forecasts For Other Formulations, 2016 – 2030 (USD Million)
Chapter 7 Europe Medical Foods Market: Application Estimates & Trend Analysis
7.1 Europe Medical Foods Market: Application Movement Analysis, 2021 & 2030, USD Million
7.2 Chronic Kidney Diseases
7.2.1 Europe Medical Foods Market Estimates And Forecasts For Chronic Kidney Diseases, 2016 – 2030 (USD Million)
7.3 Minimal Hepatic Encephalopathy
7.3.1 Europe Medical Foods Market Estimates And Forecasts For Minimal Hepatic Encephalopathy, 2016 – 2030 (USD Million)
7.4 Chemotherapy Induced Diarrhea
7.4.1 Europe Medical Foods Market Estimates And Forecasts For Chemotherapy Induced Diarrhea, 2016 – 2030 (USD Million)
7.5 Pathogen Related Infection
7.5.1 Europe medical foods market estimates and forecasts for pathogen related infections, 2016 – 2030 (USD million)
7.6 Diabetic Neuropathy
7.6.1 Europe Medical Foods Market Estimates And Forecasts For Diabetic Neuropathy, 2016 – 2030 (USD Million)
7.7 ADHD
7.7.1 Europe Medical Foods Market Estimates And Forecasts For ADHD, 2016 – 2030 (USD Million)
7.8 Depression
7.8.1 Europe Medical Foods Market Estimates And Forecasts For Depression, 2016 – 2030 (USD Million)
7.9 Alzheimer’s Disease
7.9.1 Europe Medical Foods Market Estimates And Forecasts For Alzheimer’s Disease, 2016 – 2030 (USD Million)
7.10 Nutritional Deficiency
7.10.1 Europe Medical Foods Market Estimates And Forecasts For Nutritional Deficiency, 2016 – 2030 (USD Million)
7.11 Orphan Diseases
7.11.1 Europe Medical Foods Market Estimates And Forecasts For Orphan Diseases, 2016 – 2030 (USD Million)
7.11.2 Phenylketonuria
7.11.2.1 Europe Medical foods market estimates and Forecasts for Phenylketonuria, 2016 – 2030 (USD Million)
7.11.3 Eosinophilic Esophagitis
7.11.3.1 Europe Medical foods market estimates and Forecasts for Eosinophilic Esophagitis, 2016 – 2030 (USD Million)
7.11.4 FPIES
7.11.4.1 Europe Medical foods market estimates and Forecasts for FPIES, 2016 – 2030 (USD Million)
7.11.5 Other Orphan Diseases
7.11.5.1 Europe Medical foods market estimates and Forecasts for Other orphan diseases, 2016 – 2030 (USD Million)
7.12 Wound Healing
7.12.1 Europe Medical Foods Market Estimates And Forecasts For Wound Healing, 2016 – 2030 (USD Million)
7.13 Chronic Diarrhea
7.13.1 Europe Medical Foods Market Estimates And Forecasts For Chronic Diarrhea, 2016 – 2030 (USD Million)
7.14 Constipation Relief
7.14.1 Europe Medical Foods Market Estimates And Forecasts For Constipation Relief, 2016 – 2030 (USD Million)
7.15 Protein Booster
7.15.1 Europe Medical Foods Market Estimates And Forecasts For Protein Booster, 2016 – 2030 (USD Million)
7.16 Dysphagia
7.16.1 Europe Medical Foods Market Estimates And Forecasts For Dysphagia, 2016 – 2030 (USD Million)
7.17 Other Diseases
7.17.1 Europe Medical Foods Market Estimates And Forecasts For Other Diseases, 2016 – 2030 (USD Million)
7.17.2 Parkinson’s Disease
7.17.2.1 Europe Medical foods market estimates and Forecasts for Parkinson’s Disease, 2016 – 2030 (USD Million)
7.17.3 Epilepsy
7.17.3.1 Europe Medical foods market estimates and Forecasts for Epilepsy, 2016 – 2030 (USD Million)
7.17.4 Pain Management
7.17.4.1 Europe Medical foods market estimates and Forecasts for Pain Management, 2016 – 2030 (USD Million)
7.17.5 Other Cancer Related Treatments
7.17.5.1 Europe Medical foods market estimates and Forecasts for Other Cancer Related Treatments, 2016 – 2030 (USD Million)
Chapter 8 Europe Medical Foods Market: Sales Channel Estimates & Trend Analysis
8.1 Europe Medical Foods Market: Sales Channel Movement Analysis, 2021 & 2030, USD Million
8.2 Online Sales
8.2.1 Europe Medical Foods Market Estimates And Forecasts For Online Sales Channel, 2016 – 2030 (USD Million)
8.3 Retail Sales
8.3.1 Europe Medical Foods Market Estimates And Forecasts For Retail Sales Channel, 2016 – 2030 (USD Million)
8.4 Institutional Sales
8.4.1 Europe Medical Foods Market Estimates And Forecasts For Institutional Sales Channel, 2016 – 2030 (USD Million)
Chapter 9 Europe Medical Foods Market: Regional Estimates and Trend Analysis, by Route of Administration, Product, Payment Scheme, Application, & Sales Channel
9.1 Europe Medical Foods Market: Regional Movement Analysis, 2020 & 2028, USD Million
9.2 Europe
9.2.1 Europe Medical Foods Market Estimates And Forecasts, 2016 – 2030 (USD Million)
9.2.2 U.K.
9.2.2.1 Market estimates and forecasts, by route of administration, product type, application, and sales channel, 2016 – 2030 (USD Million)
9.2.3 Germany
9.2.3.1 Market estimates and forecasts, by route of administration, product type, application, and sales channel, 2016 – 2030 (USD Million)
9.2.4 France
9.2.4.1 Market estimates and forecasts, by route of administration, product type, application, and sales channel, 2016 – 2030 (USD Million)
9.2.5 Italy
9.2.5.1 Market estimates and forecasts, by route of administration, product type, application, and sales channel, 2016 – 2030 (USD Million)
9.2.6 Spain
9.2.6.1 Market estimates and forecasts, by route of administration, product type, application, and sales channel, 2016 – 2030 (USD Million)
9.2.7 Russia
9.2.7.1 Market estimates and forecasts, by route of administration, product type, application, and sales channel, 2016 – 2030 (USD Million)
Chapter 10 Competitive Landscape
10.1 Company Profiles
10.1.1 DANONE
10.1.1.1 Company Overview
10.1.1.2 Financial Performance
10.1.1.3 Product Benchmarking
10.1.1.4 Strategic Initiatives
10.1.2 NESTLE
10.1.2.1 Company Overview
10.1.2.2 Financial Performance
10.1.2.3 Product Benchmarking
10.1.2.4 Strategic Initiatives
10.1.3 ABBOTT
10.1.3.1 Company Overview
10.1.3.2 Financial Performance
10.1.3.3 Product Benchmarking
10.1.3.4 Strategic Initiatives
10.1.4 TARGETED MEDICAL PHARMA INC
10.1.4.1 Company Overview
10.1.4.2 Financial Performance
10.1.4.3 Product Benchmarking
10.1.4.4 Strategic Initiatives
10.1.5 MEAD JOHNSON & COMPANY, LLC
10.1.5.1 Company Overview
10.1.5.2 Financial Performance
10.1.5.3 Product Benchmarking
10.1.5.4 Strategic Initiatives
10.1.6 FRESENIUS KABI AG
10.1.6.1 Company Overview
10.1.6.2 Financial Performance
10.1.6.3 Product Benchmarking
10.1.4.4 Strategic Initiatives


List of Tables

Table 1 List of secondary data
Table 2 Europe medical foods market, by country, 2016 - 2030 (USD Million)
Table 3 Europe medical foods market, by route of administration, 2016 - 2030 (USD Million)
Table 4 Europe medical foods market, by product type, 2016 - 2030 (USD Million)
Table 5 Europe medical foods market, by application, 2016 - 2030 (USD Million)
Table 6 Europe orphan diseases specific medical foods market, by application, 2016 - 2030 (USD Million)
Table 7 Europe medical foods market, by sales channel, 2016 - 2030 (USD Million)
Table 8 U.K. medical foods market, by route of administration, 2016 - 2030 (USD Million)
Table 9 U.K. medical foods market, by product type, 2016 - 2030 (USD Million)
Table 10 U.K. medical foods market, by application, 2016 - 2030 (USD Million)
Table 11 U.K. orphan diseases specific medical foods market, by application, 2016 - 2030 (USD Million)
Table 12 U.K. medical foods market, by sales channel, 2016 - 2030 (USD Million)
Table 13 Germany medical foods market, by route of administration, 2016 - 2030 (USD Million)
Table 14 Germany medical foods market, by product type, 2016 - 2030 (USD Million)
Table 15 Germany medical foods market, by application, 2016 - 2030 (USD Million)
Table 16 Germany orphan diseases specific medical foods market, by application, 2016 - 2030 (USD Million)
Table 17 Germany medical foods market, by sales channel, 2016 - 2030 (USD Million)
Table 18 France medical foods market, by route of administration, 2016 - 2030 (USD Million)
Table 19 France medical foods market, by product type, 2016 - 2030 (USD Million)
Table 20 France medical foods market, by application, 2016 - 2030 (USD Million)
Table 21 France orphan diseases specific medical foods market, by application, 2016 - 2030 (USD Million)
Table 22 France medical foods market, by sales channel, 2016 - 2030 (USD Million)
Table 23 Italy medical foods market, by route of administration, 2016 - 2030 (USD Million)
Table 24 Italy medical foods market, by product type, 2016 - 2030 (USD Million)
Table 25 Italy medical foods market, by application, 2016 - 2030 (USD Million)
Table 26 Italy orphan diseases specific medical foods market, by application, 2016 - 2030 (USD Million)
Table 27 Italy medical foods market, by sales channel, 2016 - 2030 (USD Million)
Table 28 Spain medical foods market, by route of administration, 2016 - 2030 (USD Million)
Table 29 Spain medical foods market, by product type, 2016 - 2030 (USD Million)
Table 30 Spain medical foods market, by application, 2016 - 2030 (USD Million)
Table 31 Spain orphan diseases specific medical foods market, by application, 2016 - 2030 (USD Million)
Table 32 Spain medical foods market, by sales channel, 2016 - 2030 (USD Million)
Table 33 Russia medical foods market, by route of administration, 2016 - 2030 (USD Million)
Table 34 Russia medical foods market, by product type, 2016 - 2030 (USD Million)
Table 35 Russia medical foods market, by application, 2016 - 2030 (USD Million)
Table 36 Russia orphan diseases specific medical foods market, by application, 2016 - 2030 (USD Million)
Table 37 Russia medical foods market, by sales channel, 2016 - 2030 (USD Million)

List of Figures

Fig. 1 Europe medical foods market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Europe medical foods market summary, 2021 (USD Million)
Fig. 6 Medical foods market trends & outlook
Fig. 7 Parent market analysis, 2021
Fig. 8 Company market share analysis, 2021
Fig. 9 Company market position analysis
Fig. 10 Company market ranking, by region
Fig. 11 Regional Map
Fig. 12 Company market position analysis
Fig. 13 Europe Medical foods market, route of administration outlook: Key takeaways, USD Million
Fig. 14 Europe medical foods market: ROA movement analysis, 2021 & 2030 (USD Million)
Fig. 15 Oral medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 16 Enteral medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 17 Europe medical foods market, product type outlook: Key takeaways, USD Million
Fig. 18 Europe medical foods market: Product type movement analysis, 2021 & 2030 (USD Million)
Fig. 19 Europe medical foods market estimates and forecasts for pills formulation, 2016 - 2030 (USD Million)
Fig. 20 Europe medical foods market estimates and forecasts for powder formulation, 2016 - 2030 (USD Million)
Fig. 21 Europe medical foods market estimates and forecasts for other formulations, 2016 - 2030 (USD Million)
Fig. 22 Europe medical foods market, application outlook: Key takeaways, USD Million
Fig. 23 Europe medical foods market: application movement analysis, 2021 & 2030 (USD Million)
Fig. 24 Europe medical foods market estimates and forecasts for chronic kidney diseases, 2016 - 2030 (USD Million)
Fig. 25 Europe medical foods market estimates and forecasts for minimal hepatic encephalopathy, 2016 - 2030 (USD Million)
Fig. 26 Europe medical foods market estimates and forecasts for chemotherapy-induced diarrhea, 2016 - 2030 (USD Million)
Fig. 27 Europe medical foods market estimates and forecasts for pathogen-related infections, 2016 - 2030 (USD Million)
Fig. 28 Europe medical foods market estimates and forecasts for diabetic neuropathy, 2016 - 2030 (USD Million)
Fig. 29 Europe medical foods market estimates and forecasts for ADHD, 2016 - 2030 (USD Million)
Fig. 30 Europe medical foods market estimates and forecasts for depression, 2016 - 2030 (USD Million)
Fig. 31 Europe medical foods market estimates and forecasts for Alzheimer’s disease, 2016 - 2030 (USD Million)
Fig. 32 Europe medical foods market estimates and forecasts for nutritional deficiency, 2016 - 2030 (USD Million)
Fig. 33 Europe medical foods market estimates and forecasts for orphan diseases, 2016 - 2030 (USD Million)
Fig. 34 Europe medical foods market estimates and forecasts for phenylketonuria, 2016 - 2030 (USD Million)
Fig. 35 Europe medical foods market estimates and forecasts for eosinophilic esophagitis, 2016 - 2030 (USD Million)
Fig. 36 Europe medical foods market estimates and forecasts for FPIES, 2016 - 2030 (USD Million)
Fig. 37 Europe medical foods market estimates and forecasts for other orphan diseases, 2016 - 2030 (USD Million)
Fig. 38 Europe medical foods market estimates and forecasts for wound healing, 2016 - 2030 (USD Million)
Fig. 39 Europe medical foods market estimates and forecasts for chronic diarrhea, 2016 - 2030 (USD Million)
Fig. 40 Europe medical foods market estimates and forecasts for constipation relief, 2016 - 2030 (USD Million)
Fig. 41 Europe medical foods market estimates and forecasts for protein booster, 2016 - 2030 (USD Million)
Fig. 42 Europe medical foods market estimates and forecasts for dysphagia, 2016 - 2030 (USD Million)
Fig. 43 Europe medical foods market estimates and forecasts for other diseases, 2016 - 2030 (USD Million)
Fig. 44 Europe medical foods market estimates and forecasts for Parkinson’s disease, 2016 - 2030 (USD Million)
Fig. 45 Europe medical foods market estimates and forecasts for epilepsy, 2016 - 2030 (USD Million)
Fig. 46 Europe medical foods market estimates and forecasts for pain management, 2016 - 2030 (USD Million)
Fig. 47 Europe medical foods market estimates and forecasts for other cancer-related treatments, 2016 - 2030 (USD Million)
Fig. 48 Europe medical foods market, sales channel outlook: Key takeaways, USD Million
Fig. 49 Europe medical foods market: Sales channel movement analysis, 2020 & 2028 (USD Million)
Fig. 50 Europe medical foods market estimates and forecasts for an online sales channel, 2016 - 2030 (USD Million)
Fig. 51 Europe medical foods market estimates and forecasts for a retail sales channel, 2016 - 2030 (USD Million)
Fig. 52 Europe medical foods market estimates and forecasts for an institutional sales channel, 2016 - 2030 (USD Million)
Fig. 53 Regional marketplace: Key takeaways
Fig. 54 Europe medical foods market: Regional movement analysis, 2021 & 2030 (USD Million)
Fig. 55 Europe medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 56 U.K. medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 57 Germany medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 58 France medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 59 Spain medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 60 Italy medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 61 Russia medical foods market estimates and forecasts, 2016 - 2030 (USD Million)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GRV22JL005 )"医療食品のヨーロッパ市場2022~2030:投与経路別、製品タイプ別、用途別、販売チャネル別、国別" (英文:Europe Medical Foods Market Size, Share & Trends Analysis Report By Route Of Administration, By Product Type, By Application, By Sales Channel, By Country, And Segment Forecasts, 2022 - 2030)はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。